Research ExplorerJournalsMOL CANCER THER

MOL CANCER THER - Molecular cancer therapeutics

Bibliographical data

ISSNs1535-7163
Electronic ISSN 1538-8514

Publications

An EGFR-induced Drosophila lung tumor model identifies alternative combination treatments
Bossen, J., Uliczka, K., Steen, L., Pfefferkorn, R., Mai, M. M-Q., Burkhardt, L., Spohn, M., Bruchhaus, I., Fink, C., Heine, H. & Roeder, T., 09.2019, In: MOL CANCER THER. 18, 9, p. 1659-1668 10 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Nanobody-targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies
Tintelnot, J., Baum, N., Schultheiss, C., Braig, F., Trentmann, M., Finter, J., Fumey, W., Bannas, P., Fehse, B., Riecken, K., Schütze, K., Bokemeyer, C., Rösner, T., Valerius, T., Peipp, M., Koch-Nolte, F. & Binder, M., 04.2019, In: MOL CANCER THER. 18, 4, p. 823-833 11 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib
Press, M. F., Ellis, C. E., Gagnon, R. C., Grob, T. J., Buyse, M., Villalobos, I., Liang, Z., Wu, S., Bang, Y-J., Qin, S-K., Chung, H. C., Xu, J., Park, J. O., Jeziorski, K., Afenjar, K., Ma, Y., Estrada, M. C., Robinson, D. M., Scherer, S. J., Sauter, G., Hecht, J. R. & Slamon, D. J., 01.2017, In: MOL CANCER THER. 16, 1, p. 228-238 11 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
Berte, N., Piée-Staffa, A., Piecha, N., Wang, M., Borgmann, K., Kaina, B. & Nikolova, T., 11.2016, In: MOL CANCER THER. 15, 11, p. 2665-2678 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Yu, Y., Schönlein, M., Kaufmann, A. M., Dörken, B. & Schmitt, C. A., 05.2016, In: MOL CANCER THER. 15, 5, p. 1074-81 8 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma
Ilieva, K. M., Correa, I., Josephs, D. H., Karagiannis, P., Egbuniwe, I. U., Cafferkey, M. J., Spicer, J. F., Harries, M., Nestle, F. O., Lacy, K. E. & Karagiannis, S. N., 12.2014, In: MOL CANCER THER. 13, 12, p. 2769-83 15 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1)
Decker, S., Finter, J., Forde, A. J., Kissel, S., Schwaller, J., Mack, T. S., Kuhn, A., Gray, N., Follo, M., Jumaa, H., Burger, M., Zirlik, K., Pfeifer, D., Miduturu, C. V., Eibel, H., Veelken, H. & Dierks, C., 05.2014, In: MOL CANCER THER. 13, 5, p. 1231-45 15 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells
Happold, C., Roth, P., Silginer, M., Florea, A-M., Lamszus, K., Frei, K., Deenen, R., Reifenberger, G. & Weller, M., 2014, In: MOL CANCER THER. 13, 4, p. 948-961 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer
Henningsen, M., zu Eulenburg, C., Kolarova, T., Qi, J. W., Manivong, K., Chalukya, M., Dering, J., Anderson, L., Ginther, C., Meuter, A., Winterhoff, B., Jones, S., Velculescu, V. E., Venkatesan, N., Rong, H-M., Dandekar, S., Udar, N., Jänicke, F., Los, G., Slamon, D. J. & Konecny, G. E., 01.06.2013, In: MOL CANCER THER. 12, 6, p. 1002-15 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib
Giovannetti, E., Zucali, P. A., Peters, G. J., Cortesi, F., D'Incecco, A., Smit, E. F., Falcone, A., Burgers, J. A., Santoro, A., Danesi, R., Giaccone, G. & Tibaldi, C., 03.2010, In: MOL CANCER THER. 9, 3, p. 581-93 13 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (16)